Compare COYA & NMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | NMI |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.7M | 114.5M |
| IPO Year | 2022 | 1995 |
| Metric | COYA | NMI |
|---|---|---|
| Price | $3.24 | $9.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.21 | N/A |
| AVG Volume (30 Days) | ★ 166.4K | 66.8K |
| Earning Date | 11-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,945,753.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $335.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.57 | N/A |
| 52 Week Low | $2.72 | $9.10 |
| 52 Week High | $6.62 | $11.28 |
| Indicator | COYA | NMI |
|---|---|---|
| Relative Strength Index (RSI) | 36.25 | 57.21 |
| Support Level | N/A | $9.10 |
| Resistance Level | $5.17 | $10.97 |
| Average True Range (ATR) | 0.35 | 0.20 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 32.91 | 79.69 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Nuveen Municipal Income Fund Inc is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income exempt from federal income tax, which it seeks to achieve by investing mainly in a diversified portfolio of tax-exempt municipal obligations.